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The  treatment of  Pneumococcus Type I  pneumonia with  Type 
I  antipneumococcus serum has  come into  extensive use  since  the 
original studies in 1913 by Cole  1 and his  coworkers.  These investi- 
gators found that Pneumococcus  Type I pneumonia, when not treated 
with serum exhibited a  mortality rate of about 25  per cent.  In a 
large series of serum-treated cases,  however, they showed that the 
mortality rate  could be  reduced from this  high  figure to  approxi- 
mately 7 per cent.  In spite of these convincing studies, Type I anti- 
pneumococcus serum has not come into such wide use as its efficacy 
would  seem to  justify.  The reasons for this  are  several.  Among 
them may be mentioned lack of familiarity with the subject, inex- 
perience with the technique of admini'stering serum, difficulty in ob- 
taining a  prompt determination of the type of pneumococcus, and 
finally a  certain skepticism among many physicians as to the thera- 
peutic value of serum treatment.  Especially in  the Army, in  the 
various base hospitals where Type I  antipneumococcus serum was 
used extensively, able  clinicians were often heard to express doubt 
as to the usefulness of any kind of serum treatment in pneumonia. 
The proper administration of Type I  antipneumococcus serum in 
Pneumococcus Type I  pneumonia has been followed,  in the case of 
human beings, by excellent results, as  many hospital  records show. 
So far as known, however, no test of its value has ever been made in 
1 Cole, R., J. Am. Med. Assn.,  1913,  Ixi, 663; 1917,  lxix,  505; Arch. Int. Med., 
1914,  xiv,  56. 
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experimental pneumonia in animals when treated and untreated cases 
could  be  compared  simultaneously.  The  studies  of  experimental 
pneumonia in monkeys which have been previously presented  2 show 
that  pneumococcus pneumonia in  monkeys differs  in  no  essential 
respect either clinically or pathologically from pneumococcus pneu- 
monia  in  man.  The present  study was  undertaken,  therefore,  to. 
determine by experiments on monkeys the therapeutic value of Type 
I  antipneumococcus serum in Pneumococcus Type I pneumonia. 
Method. 
The Philippine  Macacus  (Macacus syrichtus)  was  used in all the 
experiments reported in this paper.  Pneumococcus Type I pneumo- 
nia was induced in them, according to the method previously  described, 
by the intratracheal  injection  of  a  highly virulent Pneumococcus 
Type I in amounts which experience had shown invariably produced 
a fatal pneumonia. 
Type I  antipneumococcus serum, prepared by the New York State 
Board of Health, was employed throughout.  The serum, which was 
in  no  case administered until  the  animal  had  developed  definite 
symptoms of pneumonia, was diluted in most instances with an equal 
quantity of normal salt solution, and slowly injected by means of a 
Luer syringe into the femoral vein.  The dose employed was  10  cc. 
except in one experiment where doses of 20 cc.  were given in order 
to determine the  effect of  largedosage.  The dose of antipneumo- 
coccus serum recommended for man is  90  to 100  cc.  As a  Philip- 
pine Macacus  weighs  about  one-sixteenth  as  much  as  man,  the 
monkeys, in  receiving only  10  co., got a  somewhat larger dose in 
proportion to their weight than a human being receives. 
Effect of Type I  Antipneumococcus  Serum When Administered Early in 
the Disease. 
Hospital patients suffering with Pneumococcus Type I  pneumonia 
rarely receive their first injection of serum until 24 or 48 hours after 
the onset of the disease; in many cases even more time elapses before 
2  Blake, F. G., and Cecil, R. L., Y. Exp. Med., 1920, xxxi, 403, 445, 499.  Cecil, 
R. L., and Blake, F. G., Y. Exp. Med., 1920, xxxi, 519, 657, 685. RUSSELL L.  CECIL AI~D FRANCIS G.  BLAKE 
serum  treatment  is  instituted.  In  the  experiment  about  to  be  re- 
ported serum treatment was started  24 hours after the pneumococci 
were injected into the trachea of the monkey in order to determine 
the  effect  of  antipneumococcus  serum  when  administered  early  in 
the  course  of  the  disease.  Monkey  94,  which  received  0.1  cc.  of 
Pneumococcus Type I, was treated with serum.  Monkey 93, which 
received only 0.001  cc. of  Pneumococcus Type I, served as a  control 
(Text-fig. 1). 
Experiment  /.--Monkey 94  (Text-fig.  1).  Macacus  syrichtus,  male;  weight 
4,602 gin. 
May 12, 1919.  Well  and active. 
May 14.  Well and active. 
May  15.  Well  and active.  10.35 a.m.  Intratracheal injection of 0.1  cc. of 
18 hour broth culture  of Pneumococcus  Type I  (in 1 cc. of broth).  4.10  p.m. 
Quiet.  Respirations  moderately  accelerated.  Blood  culture:  0.5  cc.  in  broth, 
Pneumococcus Type I; 0.5 cc. in agar plate,  43 colonies of Pneumococcus Type I. 
May 16, 9.55 a.m.  Appears moderately sick; huddled up on perch.  Breath- 
ing rapid and labored.  Blood culture: 0.5  cc.  in broth, Pneumococcus Type I; 
0.5 cc. in agar plate,  103 colonies of Pneumococcus Type I.  10  a.m.  Intra- 
venous injection of 10 cc. of Antipneumococcus Serum Type I plus 10 cc. of nor- 
mal  saline  solution.  No  reaction.  3.55 p.m.  Quiet.  Breathing  moderately 
accelerated.  Blood culture: 0.5 cc. in broth, no growth; 0.5 cc. in agar plate, no 
growth.  4 p.m.  Intravenous injection  of 10 cc. of Antipneumococcus  Serum 
Type I plus 10 cc. of normal saline  solution.  No reaction.  9  p.m.  Quiet  but 
appears  in  good  condition;  breathing easily.  Blood  culture:  0.5 cc. in  broth, 
no growth; 0.5  cc.  in  agar plate,  no growth.  9.30 p.m.  Intravenous injection 
of 10 cc. of Antipneumococcus  Serum  Type I plus  10 co. of normal  saline  solu- 
tion (about half of material  escaped into surrounding  tissue). 
May 17.  Appears  in good condition;  breathing easily;  temperature normal. 
10.05 a.m.  Blood culture: 0.5 cc. in broth, no growth; 0.5  cc. in agar plate,  no 
growth.  10.10  a.m.  Intravenous injection  of 10 cc. of Antipneumococcus  Serum 
Type I  plus  10  cc.  of normal saline solution.  No  reaction.  4 p.m.  Monkey 
appears  well;  breathing  normally.  Intravenous injection  of  10  cc.  of  Anti- 
pneumococcus Serum Type I  plus 10 co. of normal saline solution.  No reaction. 
May 18.  Appears in good condition; breathing  easily; temperature,  however, 
has gone up.  11 a.m.  Blood culture: 0.5 cc. in broth, no growth; 0.5 cc. in agar 
plate, no growth. 
May 19.  Monkey appears in  excellent condition; respiration  quiet and slow; 
temperature still up, however.  11.45  a.m.  Blood culture: 0.5  cc.  in broth, no 
growth; 0.5 cc. in agar plate,  no growth.  11.50  a.m.  Intravenous injection  of 
10 cc. of Antipneumococcus  Serum Type I plus 10 cc. of normal saline solution. 4  EXPEI~NTAL  PNEUMONIA.  V~ 
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No  reaction.  4.30  p.m.  Intravenous  injection  of  10 cc.  of Antipneumococcus 
Serum Type I  plus 10 cc. of normal saline solution. 
May  20.  Appears  well  and  active.  Temperature  has  fallen  to  normal by 
crisis. 
May 21 to 26.  Well and active. 
May 28.  Appears well and active.  Slight rise in temperature during past 2 
days may be due to serum disease though no other manifestations of the condi- 
tion have appeared. 
May 29.  Well. 
June 2.  Continues well. 
Monkey 93  (Text-fig.  1).  Macac~ syrichtus,  male; weight  5,110  gin.  Con- 
trol for Monkey 94. 
May 12, 1919.  Well and active. 
May 14.  Well and active. 
May 15.  Well  and active.  10.25  a.m.  Intratracheal  injection of 0.001  cc. 
of  18 hour  broth culture of Pneumococcus Type I  (in 1 cc.  of broth).  4  p.m. 
Appears well.  Blood culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5  cc. in 
agar plate,  1 colony of Pneumococcus Type I. 
May 16.  Moderately sick;  respirations  increased.  10.10  a.m.  Blood  cul- 
ture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 337 colonies of 
Pneumococcus Type I. 
May 17.  Monkey sick; respirations  rapid  and  labored;  suggestive  signs of 
involvement  of right lower lobe.  10.20  a.m.  Blood culture: 0.5  cc. in broth, 
Pneumococcus Type I; 0.5 cc. in agar plate, 500 colonies of Pneumococcus Type I. 
May  18,  10.45  a.m.  Condition  the  same;  respirations  rapid  and  labored. 
Blood culture: 0.5 cc. in broth, Pneumococcus Type I;0.5 cc~ in agar plate, 365 
colonies of Pneumococcus Type I. 
May 19.  Sick; breathing rapidly; dullness and suppressed breathing over right 
lower lobe.  11.20 a.m.  Blood culture: 0.5 cc. in broth, Pneumococcus TypeI; 
0.5 cc. in agar plate, 215 colonies of Pneumococcus Type I. 
!Viay 20.  Appears  sick;  sitting  huddled  up;  breathing  rapidly.  11.35 a.m. 
Blood culture: 0.5  cc. in broth, Pneumococcus Type I; 0.5  cc. in agar plate, 24 
colonies of Pneumococcus Type I. 
May 21.  Condition  the  same.  11.25  a.m.  Blood culture: 0.5 cc. in broth, 
Pneumococcus  Type  I;  0,5  cc.  in  agar  plate,  35  colonies of Pneumococcus 
Type I. 
May 22.  Sick; respirations  rapid  and  labored.  4.15  p.m.  Blood  culture: 
0.5 cc. in broth, Pneumococcus Type I;  0.5 cc. in agar plate, 73 colonies of Pneu- 
mococcus Type I. 
May 23.  Still  sick;  respirations  rapid  and  grunting;  marked  dullness  over 
entire right chest, and bronchial breathing.  10.55 a.m.  Blood culture: 0.5 cc. in 
broth, Pneumococcus Type I; 0.5 cc. in agar plate, 66 colonies of Pneumococcus 
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May 24.  Condition  the same.  10.45 a.m.  Blood  culture:  0.5  cc. in broth, 
Pneumococcus  Type I; 0.5 cc. in agar plate, 12 colonies of Pneumococcus Type I. 
May  25.  Still  sick;  respirations  rapid  and  grunting.  10.30 a.m.  Blood 
culture: 0.5 cc. in broth, Pneumococcus Type I;  0.5 cc. in agar plate, 3 colonies of 
Pneumococcus Type I. 
May 26.  Seems better but  still sick.  10.20 a.m.  Blood  culture: 0.5  cc. in 
broth, Pneumococcus Type I; 0.5 cc. in agar plate, 46  colonies of Pneumococcus 
Type I. 
May 27.  Appears very sick; lying on floor of cage most of time.  11.20 a.m. 
Blood  culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 750 
colonies of Pneumococcus Type I.  3.15 p.m.  Died. 
Autopsy.--May 27,  4 p.m., immediately after death. 
Anatomical Diagnosis.--Experimental  lobar pneumonia  (Pneumococcus Type 
I), fight upper, middle, and lower lobes; acute fibrinous pleuritis, right side; Pneu- 
mococcus Type I  septicemia; hypertrophy and  dilatation of the  heart;  cloudy 
swelling of viscera. 
Subject.--Large male Macacus.  Body is still warm.  Abdominal organs nor- 
mally disposed;  liver  and  kidneys  show  cloudy swelling.  Pericardial and left 
pleural cavities are normal.  There are fresh fibrinous  adhesions  throughout the 
right pleural cavity. 
Heart.--Markedly  enlarged;  the cavities on both the fight and left sides show 
considerable dilatation.  The heart muscle and valves appear normal.  Left lung. 
--Somewhat  collapsed,  pale,  and  crepitant  throughout.  Rigl~ lung.--Entire 
lung shows a massive consolidation.  It is considerably larger and heavier than the 
left lung, and its surface is covered with  dark red fibrinous  tags.  Cut  surface 
of fight lung  shows  typical  gray  hepatization.  Trachea and  bronchi.--Filled 
with frothy mucus.  Bronchial lymph glands.--Enlarged. 
Microscopic Examination.--Right  lower lobe.--A  considerable  part of the  sec- 
tion is necrotic.  Inside the  necrotic areas  there  are irregular conglomerations 
of polymorphonuclear leucocytes,  many of  them  undergoing  necrosis  and  dis- 
integration.  In  the  portion  of  the  section  which  is  still preserved,  the  tissue 
shows the typical picture of resolution associated with early organization.  There 
are swelling and desquamation of the alveolar epithelium with plugs of hyaline 
material in many of the alveoli.  A  few poorly staining pneumococci are found 
in the section.  Bronchial lymph glands.--Sinuses contain large macrophage cells 
and a moderate number of lymphoid cells. 
Autopsy  Cultures.--Heart's  blood,  Pneumococcus  Type  I;  right  bronchus, 
abundant  colonies  of Pneumococcus Type I; right lower lobe,  few  colonies  of 
Pneumococcus Type I. 
These  two  protocols  indicate  that  both  monkeys  promptly  de- 
veloped  pneumonia  following  intratracheal  inoculation  with  Pneu- 
mococcus Type I.  In Text-fig.  1 it will be seen that both monkeys RUSSELL  L.  CECIL  AND  FRANCIS  G.  BLAKE 
presented  sharp  temperature  and leucocyte reactions and both  de- 
veloped positive blood cultures.  The institution of serum treatment, 
however, in Monkey 94 had a marked effect on the temperature which 
dropped  almost immediately to normal.  Moreover,  the blood  cul- 
ture which had shown  103  colonies  per 0.5  cc.  of  blood  promptly 
became sterile following the first injection of 10  cc.  of  serum.  The 
importance of keeping up  serum treatment even after the tempera- 
ture has dropped is well shown in this experiment.  When the tem- 
perature had been practically normal for 2  days, it was decided to 
discontinue the serum  treatment.  On  the following morning, how- 
ever, the temperature was at 103.2°F., and  on  the next day it rose 
to 104.5  ° .  Serum treatment was again started and  the temperature 
dropped by crisis  from  104.5  °  to  100  °  and  remained normal there- 
after. 
There can be no reasonable doubt that in this case serum  treat- 
ment greatly shortened the course of the disease and saved the mon- 
key's life.  It received 0.1 cc. of broth culture of Pneumococcus Type 
I, a  dose which has, in our experience, been invariably fatal.  The 
control monkey received  only 0.001  cc.  of  broth  culture and died 
on  the  13th  day of  the  disease.  This  experiment also  shows  that 
serum  treatment when administered early promptly removes pneu- 
mococci from the blood, and shortens the course of the disease. 
Effect of Large Doses of Serum Administered Early in the Disease.-- 
The object of the following experiment was to produce an abortive 
form of pneumonia by frequent injections of large  doses  of  serum 
early in the disease. 
Experiment 2.--Monkey  45  (Text-fig. 2).  Macacus syrichtus, male; weight 
4,544 gin. 
July 7, 1919.  ; Well and active. 
July 8.  Well  and active.  10  a.m.  Intratracheal  injection of 0.001 cc.  of 
18 hour broth culture of Pneumococcus  Type I  (in 1 cc. of broth).  3.50 p.m. 
Seems well.  Blood  culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in 
agar plate, 3 colonies  of Pneumococcus  Type I. 
July  9,  a.m. Having  a  severe chill; respirations moderately  accderated. 
Blood culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 37 
colonies of  Pneumococcus Type I.  3 p.m.  Sitting huddled up  with  rapid 
grunting  respiration; evidently  in  pain;  marked hyperesthesia in  left  axiUa. 
Blood culture: 0.5 ec. in broth, Pneumococcus  Type I; 0.5 cc. in agar plate, 111 8  EXPER~NTAL  PI~E~ONIA.  VII 
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colonies of Pneumococcus Type I.  3.05 p.m.  Intravenous injection  ef  20  cc. 
of Aatipneumococcus Serum Type I.  9 p.m.  Appears better but still breathing 
rapidly.  Blood  culture: 0.5  cc.  in  broth, no  growth; 0.5 cc. in  agar plate,  no 
growth.  9.05p.m.  Intravenous injection of 20 cc. of Antipnetmaococcus  Serum 
Type L 
July  10.  Quiet  but  otherwise  appears  well.  Breathing  easily.  10  a.m. 
Blood  culture: 0.5  cc.  in  broth, no  growth; 0.5 cc.  in  agar plate, no growth. 
10.05  a.m.  Intravenous injection  of  20 cc.  of Antipneumococcus  Serum Type 
I.  3.45 p.m.  Quiet but otherwise appears  well.  Intravenous injection  of  20 
cc. of Antipneumococcus Serum Type L 
July  11.  Well  and  active;  breathing  easily;  appears  to  have  completely 
recovered. 
July 12.  Appears  well  and  active.  10.20 a.m.  Blood  culture:  0.5  cc.  in 
broth, no growth; 0.5 cc. in agar plate, no growth. 
July 13 to 16.  Well and active. 
Monkey 79 (Text-fig.  2).  Macacus syrichtus, male; weight 6,425 grn. 
July I0, 1919.  Well and active. 
July II.  Well and active.  I0.I0 a.m.  Intratracheal injection of 0.3  cc.  of 
18  hour  broth  culture  of  Pneumococcus  Type I.  4 p.m.  Quiet.  Blood  cul- 
ture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 11  colonies  of 
Pneumococcus Type I. 
July  12.  Appears  moderately  sick;  breathing  rapidly.  9.55  a.m.  Blood 
culture: 0.5 cc. in broth, Pneumococcus Type I; 0.5 cc. in  agar plate, 15 colonies 
of Pneumococcus Type 1.  I0  a.m.  Intravenous injection  of  20  cc.  of Anti- 
pneumococcus  S  ea3urn Type 1.  Vomited 5 minutes  later.  3.45 p.m.  Appears 
better; breathing quieter.  Blood culture: 0.5  cc.  in broth,  no growth; 0.5  cc. 
in agar plate, no growth.  4 p.m.  Intravenous injection of 20 cc.  of Antipneu- 
mococcus Serum Type I.  No reaction. 
July  13.  Quiet;  rduses food; breathing moderately accelerated.  10.30 a.m. 
Blood  culture: 0.5  cc.  in  broth, no  growth; 0.5  cc. in  agax  plate, no  growth. 
10.35 a.m.  Intravenous injection of 20 cc. of Antipneumococcus SerumType I. 
6 p.m.  Intravenous injection of 20 cc. of Antipneumococcus Serum Type I. 
July 14.  Temperature has fallen to normal by crisis.  Appears well and active. 
July 15 to 18.  Well and active. 
Both the monkeys in this experiment presented symptoms of pneu- 
monia following the intratracheal injection of Pneumococcus Type I. 
In both  there  were  sharp  temperature  and  leucocyte  reactions  and 
both monkeys promptly developed positive blood cultures.  In Mon- 
key 45  serum treatment was started 29 hours after  intratracheal in- 
jection.  Reference to Text-fig. 2 shows that the object of the  experi- 
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ture immediately returned to normal,  the blood culture became sterile 
6  hours  after  the injection  of serum,  and  4  days after intratracheal 
injection  the monkey was  entirely  well and  remained  so.  Monkey 
79 received a much larger  dose of culture  (0.3  cc.)  than  Monkey 45 
received, and for that reason the infection was not so promptly over- 
come  as  in  Monkey 45.  Even  here,  however,  four  large  doses  of 
serum were sufficient to bring the temperature down to normal, where 
it  remained  permanently.  The  blood  culture  followed  the  usual 
course in serum-treated  animals  and was sterile 6 hours after serum 
treatment  was  started.  This  experiment  shows  that  by  doubling 
the  size of the  dose  serum  treatment  was made  even more rapidly 
efficacious than  in  Experiment  1.  An  abortive  type  of pneumonia 
was produced in which the acute symptoms lasted only 24 to 48 hours. 
Effect  of  Type I  Antipneumococcus  Serum  When  Administered  Late 
in the Disease. 
In  the two preceding  experiments  the value of early serum  treat- 
ment has  been demonstrated.  In  the following experiments  it was 
desired  to  determine  the  effect of  serum  treatment  when  initiated 
late in  the disease.  In  the first monkey  (No.  99)  serum  treatment 
was not started until the 3rd day of the disease, in the second monkey 
(No.  113)  not  until  the 5th  day.  Both monkeys received doses of 
culture  (0.01  cc.)  which  without  serum  treatment  had  invariably 
proved fatal.  The control  (Monkey 112)  received the same dose of 
culture  intratracheally  and  was  treated  with  normal  horse  serum 
(Text-fig. 3). 
Experiment 3.--Monkey  99 (Text-fig. 3).  Macacus syricktus, male;  weight 
6,020 gin. 
June 4, 1919.  Well and active. 
June 5.  Well  and active.  10.30 a.m.  Intratracheal  injection of 0.01 cc. of 
18 hour broth  culture of Pneumococcus Type I  (in 1 cc. of broth).  4.30  p.m. 
Blood culture: 0.5 cc. in broth,  Pneumococcus Type I; 0.5 cc. in agar  plate,  26 
colonies of Pneumococcus Type I. 
June 6,  10.30 a.m.  Moderately  sick;  respirations  rapid.  Blood  culture: 
0.5 cc. in broth,  Pneumococcus Type I; 0.5 cc. in  agar  plate,  650  colonies of 
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June  7.  Sick; respirations rapid and  labored.  9.55 a.m.  Blood culture: 0.S 
cc. in broth, Pneumococcus Type I; 0.5  cc. in agar plate, 800  colonies of Pneu- 
mococcus Type I.  10 a.m.  Intravenous injection of 10 cc. of Antipneumococcus 
Serum Type I  plus 10 cc. of normal saline solution.  3.55  p.m.  No definite im- 
provement.  Blood culture: 0.5  cc.  in broth,  no  growth;  0.5  cc. in agar plate, 
no growth.  4 p.m.  Intravenous injection of 10 cc. of Antipneumococcus Serum 
Type  I  plus  10  cc. of  normal saline  solution.  9.15  p.m.  Still sick  but  not 
so toxic.  Blood culture:  0.5  cc. in broth, no growth; 0.5  cc. in agar  plate, no 
growth.  9.20  p.m.  Intravenous injection of 10 cc. of Antipneumococcus Serum 
Type I  plus I0 cc. of normal saline solution. 
June 8.  Temperature still elevated but monkey appears better;  respirations 
moderately  accelerated.  10.30  a.m.  Blood  culture:  0.5  cc.  in  broth,  no 
growth;  0.5  cc.  in  agar  plate, no  growth.  10.35  a.m.  Intravenous injection 
of 10 cc. of Antipneumococcus Serum Type I  plus 10 cc.  of  normal saline solu- 
tion.  4.30  p.m.  Intravenous injection of  10  cc.  of Antipneumococcus Serum 
Type I  plus 10 cc. of normal saline solution. 
June  9.  Marked  improvement; seems  fairly  well; respirations  only  moder- 
ately accelerated; temperature still elevated, however.  10.15 a.m.  Blood culture: 
0.5 cc. in broth,no growth;0.5  cc. in agar plate, no growth.  10.20  a.m.  Intra- 
venous injection of  10 cc.  of  Antipneumococcus Serum Type I  plus  10  cc.  of 
normal  saline  solution.  4  p.m.  Condition  the  same.  Intravenous  injection 
of  10  cc.  of Antipneumococcus Serum Type  I  plus  10  cc. of normal saline so- 
lution.  9  p.m.  Intravenous  injection of  10  cc.  of  Antipneumococcus  Serum 
Type I  plus 10 cc. of normal saline solution. 
June  10.  Appears in good condition  but  moderately sick.  10  a.m.  Blood 
culture: 0.5 cc. in broth, no growth; 0.5 cc. in agar plate, no growth.  10.15 a.m. 
Intravenous  injection of 10 cc. of Antipneumoeoccus Serum Type I  plus 10  cc. 
of normal saline solution.  4.15  p.m.  Intravenous injection of  10  cc.  of Anti- 
pneumococcus  Serum  Type I  plus  10  cc.  of normal saline solution.  9.15 p.m. 
Intravenous injection of I0 cc. of Antipneumococcus Serum Type I  plus 10 cc. of 
normal saline solution. 
June  I1.  Improving; more active; respirations still accelerated; dullness over 
right  lower  lobe.  10  a.m.  Blood culture: 0.5  cc. in  broth, no growth; 0.5 cc. 
in agar plate, no growth.  10.05  a.m.  Intravenous injection of  10 cc. of Anti- 
pneumococcus  Serum Type I  plus  10  ce. of  normal saline solution.  4.05  p.m. 
Intravenous injection of 10 cc. of Antipneumococcus Serum Type I  plus  10  cc. 
of normal saline solution. 
June  12.  Shows marked improvement; respirations easy; temperature falling. 
10 a.m.  Blood culture: 0.5  co. in  broth, no  growth; 0.5  cc.  in  agar  plate, no 
growth.  10.05  a.m.  Intravenous  injection  of  10  cc.  of  Antipneumococcus 
Serum Type I  plus 10 cc. of normal saline solution.  4  p.m.  Temperature nor- 
mal; condition excellent.  Intravenous injection of  10  cc.  of Antipneumococcus 
Serum Type I plus 10 cc. of normal saline solution. 
June  13,  16,  18,  24.  Continues well. 12  E3LPERI~NTAI.  PNEI~ONIA.  VII 
Monkey 113 (Text-fig. 3).  Macacus syrichtus,  male; weight 5,285 gin. 
June 4, 1919.  Well and active. 
June  5.  Well  and  active.  10.45  a.m.  Intratracheal  injection  of  0.01  cc. 
of 18 hour broth culture of Pneumococcus Type I  (in 1 cc. of broth).  4.45 p.m. 
Blood culture:  0.5  cc.  in  broth, no  growth; 0.5 cc. in agar plate,  1 colony of 
Pneumococcus Type I. 
June  6,  10.40  a.m.  Moderately  sick;  respirations  rapid.  Blood  culture: 
0.5  cc. in  broth,  Pnenmococcus  Type  I; 0.5  cc.  in agar plate,  88  colonies  of 
Pneumococcus Type I. 
June  7.  Sick;  respirations  rapid  and  labored.  10.30  a.m.  Blood  culture: 
0.5  cc.  in broth,  Pneumococcus Type I; 0.5  cc.  in  agar  plate, 400 colonies of 
Pnenmococcus Type I. 
June  8.  Sick; respirations  rapid  and  labored.  11  a.m.  Blood culture:  0.5 
cc. in broth, Pneumococcus Type I; 0.5 cc. in agar plate, 69 colonies of Pnemo- 
coccus Type I. 
June 9.  Sick; respirations rapid and labored.  10.25 a.m.  Blood culture: 0.5 cc. 
in broth, Pneumococcus Type I; 0.5  cc.  in agar plate, 17 colonies of Pneumococ- 
cus Type I.  10.30  a.m.  Intravenous  injection of 10 cc. of Antipneumococcus 
Serum Type I  plus 10 cc. of normal saline solution.  4.15 p.m.  Appears better. 
Blood culture: 0.5 cc. in broth, no growth; 0.5 cc. in agar plate, no growth.  4.20 
p.m.  Intravenous injection of 10 cc. of Antipneumococcus Serum Type I  plus 
10 cc. of normal saline solution.  9.30 p.m.  Intravenous injection of 10 cc. of 
Antipneumococcus Serum Type I  plus 10 cc. of normal saline solution. 
June  10.  Appears  better  and  fairly  active;  temperature  still  elevated  and 
respirations  moderately rapid.  10.15 a.m.  Blood culture: 0.5 cc. in broth, no 
growth;.0.5 cc. in agar plate,  no growth.  10.20  a.m.  Intravenous injection of 
10 cc. of Antipneumococcus Serum Type I  plus 10 cc. of normal saline solution. 
4.20 p.m.  Intravenous injection of 10 cc. of Antipneumococcus Serum Type I 
plus 10 cc. of normal saline solution.  9.30 p.m.  Intravenous injection of 10 cc. 
of Antipnenmococcus Serum Type I  plus 10 cc. of normal saline solution. 
June 11.  Monkey appears much better; respirations still slightly accelerated. 
10.15 a.m.  Blood culture: 0.5 cc. in broth, no growth; 0.5 cc. in agar plate,  no 
growth.  10.20 a.m.  Intravenous injection of 10 cc. of Antipneumococcus Serum 
Type I  plus 10 cc. of normal saline solution.  4.20 p.m.  Intravenous injection 
of 10 cc. of Antipneumococcus Serum Type I plus 10 cc. of normal saline solution. 
June  12.  Appears in good condition.  10.15  a.m.  Blood culture: 0.5  cc. in 
broth,  no  growth; 0.5  cc.  in  agar plate,  no growth.  10.20  a.m.  Intravenous 
injection  of  10  cc.  of Antipneumococcus Serum Type I  plus  10  cc.  of normal 
saline solution.  4.10 p.m.  In excellent condition; temperature  fMllng.  Intra- 
venous injection of 10 cc. of Antipneumococcus Serum Type I  plus 10 cc. of nor- 
mal saline solution. 
June 13, 14, 17, 24.  Remains well. PN£UlqOCOCC/  /::;~,~R  o.5~  ¢.  OF  ~L OOO(~-,,~ 
9 
~  ....  3 
.~ ~..-  3 
"~ ~ "~---  S 
] 
....  .I' 
-) 
1 
J 
%, 
) 
( 
--...,, 
I 
z> 
J 
13 
h-4 
"oa 
v  ¸ 
0 
• r..~ 
0 
o~ lz~  EXPEI~rMENTAL  PNEUMONIA.  VII 
These  two  protocols  show  that  even  when  serum  treatment  is 
started late in the disease the life of the monkey may still be saved. 
The number of injections necessary, however, to achieve success was 
much  larger  than  in  the  previous  experiments  in  which  treatment 
was started  earlier.  Monkey 99  received  0.01  cc.  of  broth  culture 
of  Pneumococcus  Type  I  intratracheally  and  promptly  developed 
pneumonia.  48  hours  after  the  inoculation  serum  treatment  was 
started, in injections of  10  cc. each, administered  two or three times 
each day.  This treatment was kept up for 6 days before the tempera- 
ture  finally  became normal.  It will be seen,  however,  that  in  this 
experiment as in the previous ones, the blood, which was heavily in- 
fected when treatment was started, became immediately sterile after 
the  institution  of  serum treatment.  In Monkey 113  the procedure 
was the same as with Monkey 99, except that  serum treatment was 
delayed until  96 hours  (4 days)  after  the intratracheal  injection  of 
pneumococci.  Serum  treatment  was  continued  4  days  before  the 
temperature returned to normal.  As the infecting dose in both these 
monkeys  was  well  above  the  minimum  lethal  dose,  there  is  every 
reason to believe that both monkeys would have died from the infec- 
tion if serum treatment had not been employed.  This opinion is well 
supported by the death of the control (Monkey 112).  These experi- 
ments show that with delay in the institution of serum treatment  so 
prompt a cure cannot be expected as when treatment is started  early 
in the disease,  and  they emphasize,  therefore,  very strongly the im- 
portance and value of early treatment. 
Effect  of  Normal  Horse  Serum.--The  control  in  this  experiment 
(Monkey 112)  was treated with normal horse serum in order to de- 
termine whether non-specific factors played any part in the favorable 
results  obtained  with  antipneumococcus  serum.  The  monkey  re- 
ceived 0.01  cc.  of broth  culture  of Pneumococcus Type I  intratra- 
cheally,  and 48  hours later  serum  treatment  was started,  the injec- 
tions paralleling  those of Monkey 99. 
Monkey 112 (Text-fig. 3).  Macacus syrichtus, male; weight 3,975 gin. 
June 4, 1919.  Well  and active. 
June  5.  Well and  active.  10.50 a.m.  Intratracheal  injection  of  0.01 cc. 
of 18 hour  broth  culture  of Pneumococcus Type I  (in  1 cc. of  broth).  4.50 
p.m.  Blood culture:  0.5  cc.  in  broth,  Pneumococcus Type I; 0.5  cc. in  agar 
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June  6,  10.45  a.m.  Moderately  sick;  respirations  accelerated.  Blood  cul- 
ture: 0.5 cc. in broth, Pneumococcus I; 0.5 cc. in agar plate, 52 colonies of Pneu- 
mococcus I, 
June  7,  10.20  a.m.  Monkey  sick;  respirations rapid  and  labored.  Blood 
culture: 0.5  cc.  in broth, Pneumococcus I; 0.5  cc.  in agar plate, 51  colonies of 
Pneumococcus I.  10.22  a.m.  Intravenous injection of  10  cc.  of normal horse 
serum  plus  10  cc.  of normal  saline  solution.  No  reaction.  4.10  p.m.  Blood 
culture: 0.5  cc. in  broth,  Pneumococcus I; 0.5  cc. in agar plate, 90  colonies of 
Pneumococcus  I.  4.15  p.m.  Intravenous  injection of  10  cc.  of  normal  horse 
serum plus 10 cc. of normal saline solution.  9.30 p.m.  Sick; respirations rapid 
and labored.  Blood culture: 0.5  cc.  in broth,  Pneumococcus I; 0.5  cc. in agar 
plate,  21  colonies of  Pneumococcus  I.  9.35  p.m.  Intravenous  injection of  10 
cc. of normal horse serum plus 10 cc. of normal saline solution. 
June  8.  Sick; respirations rapid and  grunting.  10.40  a.m.  Blood culture: 
0.5  cc. in broth, Pneumococcus I; 0.5  cc. in agar plate, 17  colonies of Pneumo- 
coccus I.  10.45  a.m.  Intravenous  injection of  10  cc.  of normal horse  serum 
plus 10 cc. of normal saline solution.  5 p.m.  Intravenous injection of 10 cc. of 
normal horse serum plus 10  cc. of normal saline solution. 
June 9.  Very sick; respirations rapid and labored; dullness, bronchial breath- 
ing,  and  r~les  throughout  right  axilla.  10.45  a.m.  Blood  culture:  0.5  cc.  in 
broth, Pneumococcus I; 0.5  cc. in agar plate, 305  colonies of Pneumococcus I. 
10.50  a.m.  Intravenous injection of 10 cc. of normal horse serum plus 10 cc. of 
normal saline solution.  4.30 p.m.  Very sick.  Intravenous injection of 10  cc. 
of normal horse serum plus 10 cc. of normal saline solution.  10 p.m.  Very sick. 
Intravenous injection of 10 cc. of normal horse serum plus 10 cc. of normal saline 
solution. 
June  10.  Very sick; respirations rapid and labored.  10.30  a.m.  Blood cul- 
ture: 0.5 cc. in broth, Pneu~mococcus I; 0.5 cc. in agar plate, innumerable colonies 
of  Pneumococcus  I.  10.35  a.m.  Intravenous  injection  of  10  cc.  of  normal 
horse  serum  plus  10  cc.  of  normal  saline  solution.  4.30  p.m.  Intravenous 
injection of 10  cc. of normal horse serum plus 10  cc. of normal saline solution. 
8.30 p.m.  Died. 
Autopsy.--Performed June  11, 9.30 a.m. 
Anatomical Diagnosis.--Experimental lobar pneumoni~  (Pneumococcus Type 
I); red and gray hepatization of right middle and lower lobes; engorgement of 
left lower lobe;  acute fibrinous pleuritis, right  side; hypertrophy of  the heart; 
cloudy swelling of viscera; Pneumococcus Type I  septicemia. 
Sulv'ect.--Large male Macacus.  Postmortem rigidity is present.  Abdominal 
organs  show  cloudy  swelling but  otherwise  are  normal.  Pericardial and  left 
pleural cavities are normal.  There are a  few fine fresh adhesions over the right 
lower lobe. 
Heart.--Definitely  enlarged  and  left  ventricular  wall  appears  thicker  than 
normal.  Myocardium and valves show no changes.  Right  lung.--Considerably ]6  EXPERIMENTAL  PI~UMONIA.  VII 
larger than the left, due to massive consolidation  of the middle and lower lobes, 
and emphysema of upper lobe.  The latter is pale and air-containing  throughout. 
The middle and lower lobes are completely consolidated and are plastered together 
by fibrin.  There is also a fibrinous exudate on the surface.  The cut surface of 
the  consolidated  lobes  is  pinkis h  gray,  mottled with  patches of reddi.~h hue, 
indicative of the transition from red to gray hepatization.  Left lung.--Air-con- 
taining throughout, but the posterior portion shows marked hypostatic conges- 
tion.  This is most marked in the lower lobe, the greater part of which presents 
a dark red color.  A part of this congestion may be an expression of early infec- 
tion;  that  is,  of  engorgement.  Trache~ and  bronchi.--Contain  blood-tinged 
mucus. 
Microscopic Examination.--Right  lower lobe.--Section  shows  an  exudate  of 
polymorphonuclear leucocytes which  almost  completely fills  the  alveoli.  In 
some places  the exudate also  contains many red blood cells.  In  a  few places 
resolution is beginning, as is indicated by the desquamation of epithelium and the 
disintegration of the leucocytes.  Sometimes  the dissolution  of the  cells is  so 
advanced that practically nothing remains but an amorphous residue.  There is 
little or no perivascular infiltration of leucocytes,  but there is a very noticeable 
extrava~ation  of red blood cells in the perivascular tissue.  The bronchi contain 
pus; the bronchial epithelium has been destroyed in some places.  Section stained 
for bacteria shows a moderate number of pneumococci in the alveoli.  Many of 
these,  however,  stain  poorly.  Left lower lobe.--Section  shows  engorgement  of 
all the blood vessels, including  the capillaries.  There is a  moderate amount o~ 
interstitial infiltration of leucocytes in some places.  A few pneumococci are seen 
here and there in the alveolar waJls. 
Autopsy  Cu2tures.--Heart's blood,  Pneumococcus I; right lower lobe, Pneumo- 
coccus  I. 
It is obvious from a  study of this protocol that normal horse sevam 
had  no  beneficial effect whatever on  the  pneumococcus  septicemia, 
which gradually increased in severity; nor did it have any apparent 
effect on the course of the pneumonia.  The monkey died on the 6th 
day of the disease, in spite of ten injections of horse serum. 
DISCUSSION. 
Little  discussion  is  needed  in  connection  with  the  experiments 
which  have  just  been  described.  They prove without  any  reason- 
able doubt that Type I  antipneumococcus serum has a highly specific 
therapeutic action on Pneumococcus Type I  pneumonia.  This action 
is most rapidly effective when the serum is administered early in the 
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~occus serum at frequent intervals will completely abort what would 
otherwise be a  serious and  often fatal disease.  These experiments 
also show that even when started  late  in very severe cases serum 
treatment may cure the disease, though without appreciably shorten- 
ing its  course. 
Failure to obtain favorable results with antipneumococcus serum 
can usually be charged to one or more  of  several  causes:  (1)  In- 
correct determination of the type of pneumococcus.  Pneumoeoccus 
Type I  serum is highly specific for Pneumococcus Type I pneumonia, 
and probably has no beneficial effect whatever when used in other 
types of pneumonia.  (2)  The  serum  treatment is started  too late 
in the disease.  This is one of the most frequent mistakes made in 
connection with serum treatment of pneumonia.  When this  delay 
is unavoidable, however, the present studies have shown that it is 
always worth while to use the serum late in the disease, though in 
such cases a larger number of injections may be necessary.  (3)  The 
serum is administered in too small doses.  This mistake was often 
made in the Army camp hospitals where only 40 or 50  cc.  of serum 
were injected at one time.  (4)  The serum is not given at sufficiently 
frequent intervals.  Cole  recommends that  serum be  administered 
every 8 hours.  As a matter of practice, however, in many hospitals, 
serum is given only once or twice in 24 hours and sometimes not that 
often. 
In  the  summer of 1918  there was a  small epidemic of  Pneumo- 
coccus Type I  pneumonia among the negro troops at Camp Wheeler 
in  which the mortality rate was  surprisingly high.  In  a  series  of 
twenty-nine cases of Pneumococcus Type I pneumonia that received 
Type I  antipneumococcus serum, there were ten deaths, or a mortal- 
ity rate of 34.5 per cent.  As the mortality rate of Type I pneumonia 
in cases treated with serum was only 7 per cent in the Rockefeller 
Institute  series,  it  was  evident that  there was  some defect in  the 
method of administering the serum at Camp Wheeler.  An investi- 
gation made by one of us showed that two-thirds of these cases did 
not receive serum until 48 hours or more after admission to the hos- 
pital.  One-half of  the  cases  did  not  receive the first injection of 
serum until at least 4  days after admission.  The average number 
of serum injections was three, and the total amount of serum given 18  EXPERIMENTAL PNEUMONIA.  VII 
each patient averaged about  175 cc.  From  these  figures it would 
appear that at Camp Wheeler antipneumococcus serum was not ad- 
ministered early enough, frequently enough, or in sufficiently large 
doses, to be of therapeutic value. 
Finally, it should be pointed out that two of the monkeys in the 
experiments (Nos.  45  and 79)  received doses of serum about three 
times  as  large  proportionately as  human  patients  receive in  our 
hospitals, and suffered no apparent ill effects therefrom.  This brings 
up  the  question whether even more brilliant  results  could not be 
obtained with serum treatment in man, if the routine dose of anti- 
pneumococcus serum were larger.  It would have to be determined, 
of course, whether this modification could be introduced without dis- 
comfort or danger to the patient. 
CONCLUSIONS. 
1.  In experimental Pneumococcus Type I  pneumonia in monkeys 
the intravenous injection of Type I  antipneumococcus serum exer- 
cises a  specific therapeutic effect, frees the blood promptly and per- 
manently from pneumococci, shortens the course of the disease, and 
greatly moderates its  severity.  Of  five monkeys inoculated intra- 
tracheally with lethal doses of Pneumococcus Type I, all developed 
pneumonia, and all recovered following the administration of Type 
I  antipneumococcus serum, while the controls died. 
2.  The  earlier  the  serum  is  administered  the  shorter  and  less 
severe the pneumonia.  Frequent injections are  also  an  important 
factor in obtaining favorable results.  When serum treatment is in- 
stituted late in the disease, the injections must usually be continued 
over a longer period of time in order to achieve success. 
3.  Normal  horse  serum  exerts  no beneficial effect  whatever  in 
experimental Pneumococcus Type I pneumonia. 